CD44 and neoplasm: Altered CD44 expression, including the presence of specific alternative isoforms (e.g., CD44v6), correlates with increased tumor aggressiveness and a poorer clinical prognosis in numerous types of cancer, including colon, breast, and gastric cancers, as well as leukemias.